Akbari Mehdi, Roshan Rasool, Shabani Amir, Fata Ladan, Shairi Mohamad Reza, Zarghami Firouzeh
Kharazmi University, Tehran, Iran.
Shahed University, Tehran, Iran.
Iran J Psychiatry. 2015 Jun;10(3):200-11.
The transdiagnostic cognitive behavioral treatments for treating the coexistence of anxiety and mood disorders received useful empirical supports in the recent years. However, these treatments still have moderate efficacy. Following the improvements and developments in transdiagnostic protocols and considering the importance of repetitive negative thinking as a core transdiagnostic factor in emotional disorders, this study examined a new form of transdiagnostic treatment based on Repetitive Negative Thinking (TTRNT) of co-occurrence of anxiety and depressive disorders.
Treatment efficacy was assessed using single case series with multiple baselines. Three patients meeting the criteria for co-occurrence of anxiety and depressive disorders were selected using the Anxiety Disorders Interview Schedule for DSM-IV. The patients were treated individually for 12 weekly sessions. Participants completed the standardized outcome measures during the baseline, treatment and one-month follow-up.
At post-treatment, all participants showed significant clinical changes on a range of standardized outcome measures, and these gains were largely maintained through the one-month follow-up both in the principle and co-principal diagnosis.
Although the results of this preliminary investigation indicated that TTRNT could be a time effective and efficient treatment for individuals with co-occurrence of anxiety and depressive disorders, further controlled clinical trials are necessary to examine this new treatment approach.
近年来,用于治疗焦虑症和情绪障碍共病的跨诊断认知行为疗法获得了有益的实证支持。然而,这些疗法的疗效仍处于中等水平。随着跨诊断方案的改进与发展,并考虑到重复性消极思维作为情绪障碍核心跨诊断因素的重要性,本研究考察了一种基于焦虑症和抑郁症共病的重复性消极思维(TTRNT)的新型跨诊断治疗方法。
采用具有多个基线的单病例系列评估治疗效果。使用《精神疾病诊断与统计手册》第四版焦虑症访谈量表选取了3名符合焦虑症和抑郁症共病标准的患者。患者接受为期12周的个体治疗。参与者在基线期、治疗期和1个月随访期完成标准化结局测量。
治疗后,所有参与者在一系列标准化结局测量上均显示出显著的临床变化,并且这些改善在主要诊断和共主要诊断的1个月随访期内基本得以维持。
尽管这项初步调查的结果表明,TTRNT对于焦虑症和抑郁症共病个体可能是一种省时高效的治疗方法,但仍需要进一步的对照临床试验来检验这种新的治疗方法。